NCT05563272 2025-07-10STARBURSTTelix Pharmaceuticals (Innovations) Pty LimitedPhase 2 Terminated11 enrolled
NCT03474640 2024-11-22Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesTopAlliance BiosciencesPhase 1 Completed184 enrolled 20 charts
NCT05955105 2024-05-21A Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesInnolake BiopharmPhase 1/2 Recruiting200 enrolled
NCT02822495 2023-06-15Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or MalignanciesAtara BiotherapeuticsNo longer available
NCT05415098 2022-11-16Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasAscentage Pharma Group Inc.Phase 1 Unknown90 enrolled
NCT04107142 2019-09-27Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid TumourCytoMed Therapeutics Pte LtdPhase 1 Unknown10 enrolled